The short answer
NCI's stage IV anal cancer list covers palliative surgery and radiation, chemotherapy with or without radiation, three drug pairings, and the checkpoint inhibitors nivolumab and pembrolizumab. The InterAACT trial is worth asking about by name, though it is one trial rather than the deciding word, and retifanlimab is approved for this disease but missing from the treatment summary.
NCI's stage IV list names cisplatin with fluorouracil, carboplatin with weekly paclitaxel, docetaxel with cisplatin and fluorouracil, plus nivolumab and pembrolizumab.
In the InterAACT trial, median overall survival was 20 months with carboplatin and paclitaxel against 12.3 months with cisplatin and fluorouracil, and serious adverse events were more common with cisplatin, 62% against 36%.
Retifanlimab is approved for metastatic or recurrent anal squamous cell cancer but does not appear in NCI's treatment summary. Ask which page applies to you.
NCI says people with HIV are generally treated the same and do about as well, but a pretreatment CD4 count under 200 may mean more early and late toxicity.
Choose how you want to understand this
The full explanation.
What stage IV anal cancer means here
Stage IV means the cancer has reached organs beyond the anal area. The NCI list for this stage is short and clear.
It names surgery and radiation used to ease symptoms. It names chemotherapy, with or without radiation.
Then it names the drug pairings. Cisplatin with fluorouracil. Carboplatin with weekly paclitaxel. Docetaxel with cisplatin and fluorouracil. Two more drugs sit on the list as well: nivolumab and pembrolizumab.
The chemotherapy choice, and the trial behind it
There is a trial you can ask about by name. It is called InterAACT.
It compared carboplatin plus weekly paclitaxel against fluorouracil plus cisplatin. Median survival was 20 months in the first group and 12.3 months in the second.
Serious side effects were more common with cisplatin, 62 percent against 36 percent. NCI says these results led researchers to treat carboplatin and paclitaxel as the new backbone for trials.
Immunotherapy after chemotherapy
Nivolumab and pembrolizumab both sit on the NCI list. Ask where they come in your sequence. Ask what would trigger the switch.
A newer drug the NCI summary leaves out
NCI's drug pages describe retifanlimab. It is approved for anal squamous cell cancer that has spread or come back.
It is used with carboplatin and paclitaxel as a first treatment when surgery is not possible. It is also used alone after platinum chemotherapy stops working.
The treatment summary cited below does not mention it at all. We are pointing at that gap rather than settling it. Ask your oncologist which page applies to you.
HIV and the treatment plan
NCI says people with HIV are generally treated the same way and do about as well. Modern HIV treatment is the reason.
One caution matters. A CD4 count under 200 before treatment may mean more side effects, early and late.
NCI says a history of AIDS-related illness can make a standard plan hard to tolerate. The dose may be lowered, or mitomycin may be left out.
Pain and bleeding from the tumor itself
The tumor can hurt and bleed even when the main problem is elsewhere. Radiation and surgery are both on the NCI list for that job alone.
Questions to bring
- Which chemotherapy would you start with, and why?
- Does the InterAACT result apply to me?
- When would immunotherapy come in?
- Does retifanlimab apply to my situation?
- What is my CD4 count, and does it change my doses?
- Can radiation help the pain or bleeding I have now?
- Which trial is open for me?
When to get help sooner
- Call 911 or go to an emergency department if bleeding from the back passage is heavy or will not stop, or if bleeding comes with dizziness or fainting. Go too if you have belly pain with vomiting and are passing no gas or stool, which can mean the bowel is blocked, or if you cannot pass urine at all.
- Call your care team at once, day or night, if you have a temperature of 100.4°F (38°C) or higher while on chemotherapy, and go to an emergency department if you cannot reach them quickly. A same-day call is too slow here. Chemotherapy drops the white cells that hold infection back, and CDC treats a fever during chemotherapy as a medical emergency. Tell whoever sees you which regimen you are on and when your last dose was.
- Call your care team the same day if you are on retifanlimab or another immunotherapy and have several watery stools a day, blood or mucus in your stool, a new cough or breathlessness, yellow eyes or dark urine, or a rash that is blistering or peeling. These drugs can inflame healthy organs. Ring the 24-hour oncology line rather than waiting; the team will grade the problem and check for infection before deciding how to treat it.
- Call your care team within a day or two if pain in the back passage or pelvis is getting worse and your current painkillers are not holding it. Do the same for new numbness around the buttocks or inner thighs, a discharge that smells bad, or steady bleeding that is not heavy.
Related pages
Cancer Staging and Biomarker Testing explain the terms behind a metastatic anal cancer diagnosis. Clinical Trial vs Standard Treatment, Palliative Care, and Questions to Ask Your Doctor cover the choices that come next with metastatic anal cancer.
Where this comes from
These questions were drawn from current patient guidance for anal cancer:
Words to know
Tap any term to see what it means.
Common questions
Which chemotherapy comes first?
There is no single answer, but the InterAACT trial is worth asking about by name. It compared carboplatin plus weekly paclitaxel against fluorouracil plus cisplatin. Median overall survival was 20 months against 12.3 months, and serious side effects were more common with cisplatin, 62% against 36%. NCI says these results led investigators to treat carboplatin and paclitaxel as the new backbone for trials. A trial backbone is not automatically your regimen; your kidney function, nerve symptoms, other health and whether immunotherapy is being added all feed into the choice.
What about retifanlimab?
NCI's drug pages describe it as approved for anal squamous cell cancer that has spread or come back, used with carboplatin and paclitaxel when surgery is not possible, and alone after platinum chemotherapy stops working. NCI's anal cancer treatment summary does not mention it. That is a gap to raise with your oncologist rather than one this page can settle.
Does having HIV change the plan?
NCI says people with HIV are generally treated similarly and have similar outcomes, thanks to modern antiretroviral treatment. One caution: a pretreatment CD4 count below 200 cells per microlitre may mean more acute and late toxicity, and a history of AIDS-related illness may mean a dose adjustment or leaving mitomycin out.
Questions to ask your doctor
Being prepared helps you get the most out of your appointments. Save or print these questions.
Tap a question to save it to your list (kept on this device).
Your next step
Turn this topic into questions for your next appointment.
Speak With Trained Specialists & Human Navigators
Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.
Talk to a trained cancer information specialist
Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.
Contact your oncology team
Locate after-hours contact numbers, portal messages, or urgent triage phone lines.
Find a patient navigator
Get one-on-one help with appointments, logistics, translation, and care coordination.
Find a genetic counselor
Discuss inherited mutation risk, family history, and genetic testing options.
Find an oncology social worker
Access emotional counseling, family support groups, and mental health resources.
Find a financial navigator
Locate copay assistance foundations, grant programs, and lodging/travel support.
Find a clinical-trial specialist
Search matching studies and speak with NCI trial information specialists.
Get urgent help
Immediate emergency guidance for fever (>100.4°F during chemo), severe pain, or shortness of breath.
Help Us Improve This Guide
Did this explanation answer your question and help you determine your next step?
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.
Sources last checked: 2026-08-13 what this meansLast updated: 2026-08-19Next planned review: 2027-07-30
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status — Source checked. This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.
High-risk topic — talk to your care team. This topic can involve urgent, individual medical decisions. This page is general education only: it cannot tell you whether your situation is an emergency or what you personally should do. Follow your oncology team's instructions and contact them for individual guidance.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status: Source checked — This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
Read more about our editorial process, our use of AI, and our corrections policy.
Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.
After using this page, do you understand what to do next?
Anonymous — we only record the answer, never who gave it.
Related articles
- Anal Cancer: A Plain-Language Overview
- Cancer Staging: What the Stage Means
- Biomarker Testing and Precision Medicine
- Getting a Second Opinion After a Diagnosis
- Questions to Ask About Anal Cancer Treatment
- Anal Cancer Recurrence: What to Ask
- Anal Cancer Survivorship Follow-Up Questions
- Metastatic Cancer: When Cancer Spreads
Still have questions?
Educational answers, plain language
Free to print and share